Sept. 21, 2016:

Studies show that patients with low income, the elderly, racial and ethnic minorities, women and those who live in rural areas represent the smallest percentage of clinical trial participants. Unfortunately, these groups also represent a disproportionate burden of disease. A diverse coalition of health care partners today announce the #BeAGift campaign aimed at changing perceptions of and encourage participation in clinical trials across the region and nationwide. Read More

Sept. 20, 2016:

Every month, we huddle for another edition of Across the Consortium to recap the progress of our member institutions.  This month, we celebrate new advancements that challenge traditional precepts of imaging, point to new modes of suppressing tumor growth, and identify side effects of current treatments.  You will see members procuring serious funding to answer serious questions and meeting the urgent needs of patients head on with brand new clinical trials.  Circle up!

Read More

Sept. 15, 2016:

Investigator spotlight

Jean Grem, MD, is professor of medicine and joined the University of Nebraska Medical Center (UNMC) in 2003. Prior to joining UNMC, Dr. Grem was senior investigator at the National Cancer Institute, in Bethesda, Maryland since 1986. She became the gead of the Gastrointestinal Malignancies Division, Cancer Therapeutics Branch at the National Cancer Institute in 2001. Dr. Grem is known nationally as an expert in gastrointestinal malignancies and is currently exploring several novel therapeutic approaches in both colon and pancreatic cancer at UNMC including targeting metabolic alternations to improve survival in pancreatic cancer as project four in UNMC’s pancreatic SPORE.
Read More

September 8, 2016:

Mohammed Milhem, MBBS, has joined the Big Ten Cancer Research Consortium Steering Committee, representing the Holden Comprehensive Cancer Center at the University of Iowa. The committee, composed of one representative from each member institution, meets on a regular basis to review activities of the consortium and decide matters of policy. The committee determines the criteria for approving concepts for development within the Big Ten CRC. Read More

September 7, 2016:

Researchers and leaders of Big Ten cancer centers will meet in Indianapolis Friday and Saturday for a first-ever cancer research summit among the institutions.

Representatives from 12 of the Big Ten cancer centers will meet for the inaugural Big Ten Cancer Research Consortium Summit, hosted by the Indiana University Melvin and Bren Simon Cancer Center, at the JW Marriott Indianapolis.

In addition to the consortium institutions, the meeting will bring together biotech and pharmaceutical leaders to strengthen the academic and industry collaboration and explore opportunities for novel therapeutic advances in cancer research. Read More

September 5, 2016:

The fight against cancer is ramping up like never before, and raising awareness is a key part of the strategy to defeat cancer. September is an action-packed month of awareness for the following cancers: thyroid, ovarian, prostate, gynecologic, childhood, and leukemia/lymphoma. There is much to be done, and member institutions of the Big Ten Cancer Research Consortium are leading the charge, from a first-of-its-kind clinical trial, to a unique survivorship program, to securing a prestigious grant.
Read More